Cramp Tabs

Manufacturer
Redicare LLC
Effective date
2020-01-17
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:45:41

Label at a glance#

ProductCramp Tabs
Active ingredientPAMABROM, ACETAMINOPHEN
Label structure12 sections

Indications and uses

For the relief of ■ cramps ■ a headache ■ bloating ■ backaches ■ water-weight gain ■ muscular aches and pains

Dosage and administration

Adults and children 12 years of age or older: Take 2 Tablets every 4 to 6 hours as needed, do not exceed 8 tablets in 24 hours or as directed by a doctor. Children under 12 years of age: Consult a doctor.

Label contents#

Full prescribing information#

Active Ingredients (in each tablet) Purpose

OTC - ACTIVE INGREDIENT SECTION

Acetaminophen 325 mg.............................................................................................................pain reliever/fever reducer

Pamabrom 25 mg....................................................................................................................................................diuretic

Uses:

OTC - PURPOSE SECTION

For the relief of ■ cramps ■ a headache ■ bloating ■ backaches ■ water-weight gain ■ muscular aches and pains

Liver Warning:

WARNINGS SECTION

This product contains Acetaminophen. Severe liver damage may occur if: ■ you take more than 8 tablets in 24 hours ■ you take with other drugs containing acetaminophen (prescription or non-prescription) ■ you have 3 or more alcoholic drinks every day while using this product.

Precaution:

WARNINGS SECTION

If a rare sensitivity reaction occurs, the drug should be discontinued.

Do not use:

OTC - DO NOT USE SECTION

■ with any other product containing acetaminophen, this will provide more than the recommended dose (overdose) of acetaminophen and could cause serious health concerns ■ for more than 10 days for pain unless directed by a doctor ■ for more than 3 days for fever unless directed by a doctor ■ when using this product do not exceed recommended dose

Stop use and ask a doctor if

OTC - STOP USE SECTION

■ Symptoms do not improve ■ pain gets worse or lasts for more than 10 days ■ new symptoms occur ■ redness or swelling is present

If pregnant or breast-feeding a baby,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of an overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions:

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age or older: Take 2 Tablets every 4 to 6 hours as needed, do not exceed 8 tablets in 24 hours or as directed by a doctor.
Children under 12 years of age: Consult a doctor.

Other Information:

INDICATIONS & USAGE SECTION

■ Tamper Evident. Do not use if packet is torn, cut or opened

■ Store at controlled room temperature 15˚ to 30˚C (59˚ to 86˚F)

■ Avoid excessive heat and humidity

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

Corn Starch, Microcrystalline Cellulose, Povidone, Sodium Starch Glycolate, and Stearic Acid.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Cramp TabletsCramp Tablets

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71105-70071105-700-68

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c62a1821-699d-8814-e053-2a95a90a6c6247e05711-cab1-5ee7-e054-00144ff88e882021-07-02WarningsExact identifier
spl set id: 47e05711-cab1-5ee7-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.